For pharmacokinetic and toxicokinetic purpose a simple HPLC-UV method has been developed and validated for the estimation of DRF-4848, a novel COX-2 inhibitor in rat plasma. A liquid-liquid extraction was used to extract DRF-4848 and internal standard (IS, DRF-4367) from rat plasma. The analysis was
Validation of a simple HPLC method for assay of haplamine and its metabolites in plasma suitable for pharmacokinetic application in rats
β Scribed by Sompheary Ea; Claude Aubert; Sarah Giacometti; Joseph Ciccolini; Chhan Siv; Hot Bun
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 331 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0269-3879
- DOI
- 10.1002/bmc.904
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A simple HPLC method with ultraviolet detection has been developed and validated for the simultaneous determination of haplamine and its metabolites (trans/cisβ3,4βdihydroxyhaplamine) in rat. A liquidβliquid extraction was used to extract the compounds from rat plasma. The analysis was performed on a C~18~ Nucleosil Nautilus column. The mobile phase consisted of water (A) and a mixture of methanol and acetonitrile (85:15; v/v) (B) used in gradient mode (38β40% B for 10 min, 40β58% B for 49 min, 58β38% B for 1 min, and 38% for 5 min) pumped at 1 mL/min. The calibration curves showed good linearity with correlation coefficients greater than 0.999 for the analytes in the investigated concentration range. The lower limit of detection was 0.007, 0.008 and 0.009 Β΅g/mL and the lower limit of quantification was 0.014, 0.017 and 0.018 Β΅g/mL for haplamine, and trans/cisβ3,4βdihydroxyhaplamine, respectively. The method was applied to a preliminary pharmacokinetic study in rats. This method proved to meet fully the standards required of experimental pharmacokinetic studies and should be used in further preclinical investigation. Copyright Β© 2007 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES